Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vpr is preferentially targeted by CTL during HIV-1 infection.

Altfeld M, Addo MM, Eldridge RL, Yu XG, Thomas S, Khatri A, Strick D, Phillips MN, Cohen GB, Islam SA, Kalams SA, Brander C, Goulder PJ, Rosenberg ES, Walker BD; HIV Study Collaboration. Vpr is preferentially targeted by CTL during HIV-1 infection. . J Immunol. 2001 Sep 1;167(5):2743-52. . 2001; 167(5):2743-2752.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.